A week after GlaxoSmithKline (NYSE:GSK) reached a $3 billion federal settlement over claims it illegally marketed Avandia and other drugs, the drugmaker now faces pressure to resolve the thousands of Avandia patient lawsuits that remain. Judge Cynthia Rufe, U.S. district judge for the Eastern District of Pennsylvania, appointed a mediator to oversee settlement negotiations for […]
GlaxoSmithKline took a loss in the fourth quarter of 2010 but the company's stock still managed to climb in trading Thursday. The company announced a stock buyback program that pleases investors, even as the company cuts back on R&D spending for new drugs.
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
GlaxoSmithKline has settled its first case involving former diabetes blockbuster Avandia, but it will most certainly not be the last word on the matter.
GlaxoSmithKline's Avandia problems are resulting in the company setting aside $3.4 billion to pay for legal costs related to its former diabetes drug, which has been linked to greater cardiovascular risks. Though the drug is now scarce in the European and U.S. markets thanks to greater regulatory scrutiny, GSK faces mounting expenses as Avandia legal claims continue to be filed.
Defunding by Congress and implementation by governors are the two major threats facing healthcare reform, Tom Daschle, former U.S. Senate majority leader who almost became Department of Health and Human Services nomination in the Obama administration, tells Kaiser Health News.
McDonald's Corp. has warned federal regulators that it could drop its health insurance plan for nearly 30,000 hourly restaurant workers unless regulators waive a new requirement of the U.S. health overhaul, reports the Wall Street Journal.
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.
What does Cleveland Clinic cardiologist (and Avandia whistleblower) Steven Nissen have to say about Thursday's Food and Drug Administration decision to allow diabetes drug Avandia to stay on the market with significant restrictions? "I think it's a reasonable course of action and compromise. It will limit 99 percent of its use," Nissen told the Wall Street Journal (subscription required).
Swiss drugmaker Novartis just got Food and Drug Administration approval to sell the first pill that can slow the progression of multiple sclerosis. Gilenya will go head-to-head with injectable medicines, including Avonex, Tysabri and Rebif. But how much will the MS pill cost? Novartis won't say, NPR reports.
The British Medical Journal today raised more questions about whether diabetes drug Avandia should ever have been approved for patients in the United States and Europe, and whether the drug "may be about to fold."
The two researchers whose claims of injury led a federal judge to ban research using human embryonic stem cells late Monday have a history of disputes with colleagues as well as ethical objections to embryonic stem cell research, according to the New York Times.
This webinar will explore how a banking platform approach could be the resource for your company.
Highlights of the important and the interesting from the world of healthcare: Massachusetts nurses strike on tap? After a near-miss of a lengthy nurses strike in Minnesota, some nurses in Massachusetts are close to getting into the act. The union representing North Adams Regional Hospital has voted in favor of going on strike, though negotiations […]
Highlights of the important and the interesting from the world of healthcare: Troubled nurses skip from state to state. Nurse Craig Peske was fired from a hospital in Wausau, Wisconsin, in 2007 after stealing the powerful painkiller Dilaudid. Six months later, Peske was charged with six felony counts of narcotic possession at a hospital 1,200 […]
Highlights of the important and the interesting from the world of healthcare: Is venture capital just a three-state game? It was in the second quarter, according to data from the always-insightful research firm CB Insights. A whopping 70 percent of all funding went to just three states–California, Massachusetts and New York, with California taking half […]
Could Avandia be the drug industry’s ReGen? The New York Times reported Tuesday that for over a decade, GlaxoSmithKline hid the results of its own study that showed its diabetes drug Avandia “provided clear signs that it was riskier to the heart.” The Food and Drug Administration ultimately approved Avandia. But in 2007, a doctor […]
Highlights of the important and the interesting from the world of healthcare: iPhone video chat a “game-changing tool” for doctors: Two doctors participated in what may be the first documented medical consultation conducted via the iPhone’s new FaceTime video chat function. An Arizona surgeon and a California counterpart used the application to discuss a patient who […]